Fasidotrilat
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Vasopeptidase inhibitors (VPI) are a new promising class of drugs, that simultaneously inhibit Angiotensin - Converting Enzyme…
Lilly is developing fasidotril, a diester prodrug of the active metabolite fasidotrilat, for the potential treatment of…
The acute diuretic and natriuretic effects of fasidotrilat, a mixed inhibitor of neutral endopeptidase (NEP) and angiotensin I…